Immune-inflammatory markers in patients with seasonal affective disorder

Effects of light therapy

Sy Jye Leu, I. Shin Shiah, Lakshmi N. Yatham, Yech Mei Cheu, Raymond W. Lam

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Background: There is increasing evidence that an activation of the immune-inflammatory system is involved in the pathophysiology of depressive disorders. The purposes of this study were to (1) compare immune-inflammatory markers in patients with seasonal affective disorder (SAD) with those in matched normal controls; and (2) examine the effects of light therapy on the immune-inflammatory markers in patients with SAD. Methods: Plasma concentrations of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble IL-2 receptor (sIL-2R) were measured in 15 patients with SAD and 15 age- and sex-matched normal controls. Of the 15 patients, 14 had repeated blood sampling for these variables following 2 weeks of light therapy. Results: We found that patients with SAD had significantly increased IL-6 levels compared to normal controls (P <0.0005). There was a trend toward increased sIL-2R in patients with SAD (P = 0.09). There was no significant difference in sIL-6R level between the two diagnostic groups (P = 0.18), but the product term (IL-6 × sIL-6R) was significantly higher in patients with SAD than that in normal control controls (P <0.0003). Furthermore, all 14 patients who completed the study improved with 2 weeks of light therapy and nine of them (64%) had 50% reduction in score of the Hamilton Depression Rating Scale-SAD version post-treatment compared to baseline. However, the initially increased immune markers in SAD patients were not significantly altered by the therapeutic light therapy. Limitations: This study was limited to a small sample size and other immune inflammatory markers should be measured for further evidence of immune activation in seasonal depression. Conclusions: Our results of increased IL-6, IL-6 × sIL-6R, and sIL-2R in patients with SAD suggest an activation of the immune-inflammatory system in winter depression, which is not altered by 2 weeks of successful light therapy.

Original languageEnglish
Pages (from-to)27-34
Number of pages8
JournalJournal of Affective Disorders
Volume63
Issue number1-3
DOIs
Publication statusPublished - 2001

Fingerprint

Seasonal Affective Disorder
Phototherapy
Biomarkers
Interleukin-6 Receptors
Interleukin-6
Interleukin-2 Receptors
Depression
Immune System
Depressive Disorder
Sample Size

Keywords

  • Cytokines
  • Interleukin-6
  • Light therapy
  • Seasonal affective disorder
  • Soluble interleukin-2 receptors
  • Soluble interleukin-6 receptors
  • Winter depression

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Neurology
  • Psychology(all)

Cite this

Immune-inflammatory markers in patients with seasonal affective disorder : Effects of light therapy. / Leu, Sy Jye; Shiah, I. Shin; Yatham, Lakshmi N.; Cheu, Yech Mei; Lam, Raymond W.

In: Journal of Affective Disorders, Vol. 63, No. 1-3, 2001, p. 27-34.

Research output: Contribution to journalArticle

Leu, Sy Jye ; Shiah, I. Shin ; Yatham, Lakshmi N. ; Cheu, Yech Mei ; Lam, Raymond W. / Immune-inflammatory markers in patients with seasonal affective disorder : Effects of light therapy. In: Journal of Affective Disorders. 2001 ; Vol. 63, No. 1-3. pp. 27-34.
@article{25b3d513771340f4b0b2529b7934b67a,
title = "Immune-inflammatory markers in patients with seasonal affective disorder: Effects of light therapy",
abstract = "Background: There is increasing evidence that an activation of the immune-inflammatory system is involved in the pathophysiology of depressive disorders. The purposes of this study were to (1) compare immune-inflammatory markers in patients with seasonal affective disorder (SAD) with those in matched normal controls; and (2) examine the effects of light therapy on the immune-inflammatory markers in patients with SAD. Methods: Plasma concentrations of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble IL-2 receptor (sIL-2R) were measured in 15 patients with SAD and 15 age- and sex-matched normal controls. Of the 15 patients, 14 had repeated blood sampling for these variables following 2 weeks of light therapy. Results: We found that patients with SAD had significantly increased IL-6 levels compared to normal controls (P <0.0005). There was a trend toward increased sIL-2R in patients with SAD (P = 0.09). There was no significant difference in sIL-6R level between the two diagnostic groups (P = 0.18), but the product term (IL-6 × sIL-6R) was significantly higher in patients with SAD than that in normal control controls (P <0.0003). Furthermore, all 14 patients who completed the study improved with 2 weeks of light therapy and nine of them (64{\%}) had 50{\%} reduction in score of the Hamilton Depression Rating Scale-SAD version post-treatment compared to baseline. However, the initially increased immune markers in SAD patients were not significantly altered by the therapeutic light therapy. Limitations: This study was limited to a small sample size and other immune inflammatory markers should be measured for further evidence of immune activation in seasonal depression. Conclusions: Our results of increased IL-6, IL-6 × sIL-6R, and sIL-2R in patients with SAD suggest an activation of the immune-inflammatory system in winter depression, which is not altered by 2 weeks of successful light therapy.",
keywords = "Cytokines, Interleukin-6, Light therapy, Seasonal affective disorder, Soluble interleukin-2 receptors, Soluble interleukin-6 receptors, Winter depression",
author = "Leu, {Sy Jye} and Shiah, {I. Shin} and Yatham, {Lakshmi N.} and Cheu, {Yech Mei} and Lam, {Raymond W.}",
year = "2001",
doi = "10.1016/S0165-0327(00)00165-8",
language = "English",
volume = "63",
pages = "27--34",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Immune-inflammatory markers in patients with seasonal affective disorder

T2 - Effects of light therapy

AU - Leu, Sy Jye

AU - Shiah, I. Shin

AU - Yatham, Lakshmi N.

AU - Cheu, Yech Mei

AU - Lam, Raymond W.

PY - 2001

Y1 - 2001

N2 - Background: There is increasing evidence that an activation of the immune-inflammatory system is involved in the pathophysiology of depressive disorders. The purposes of this study were to (1) compare immune-inflammatory markers in patients with seasonal affective disorder (SAD) with those in matched normal controls; and (2) examine the effects of light therapy on the immune-inflammatory markers in patients with SAD. Methods: Plasma concentrations of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble IL-2 receptor (sIL-2R) were measured in 15 patients with SAD and 15 age- and sex-matched normal controls. Of the 15 patients, 14 had repeated blood sampling for these variables following 2 weeks of light therapy. Results: We found that patients with SAD had significantly increased IL-6 levels compared to normal controls (P <0.0005). There was a trend toward increased sIL-2R in patients with SAD (P = 0.09). There was no significant difference in sIL-6R level between the two diagnostic groups (P = 0.18), but the product term (IL-6 × sIL-6R) was significantly higher in patients with SAD than that in normal control controls (P <0.0003). Furthermore, all 14 patients who completed the study improved with 2 weeks of light therapy and nine of them (64%) had 50% reduction in score of the Hamilton Depression Rating Scale-SAD version post-treatment compared to baseline. However, the initially increased immune markers in SAD patients were not significantly altered by the therapeutic light therapy. Limitations: This study was limited to a small sample size and other immune inflammatory markers should be measured for further evidence of immune activation in seasonal depression. Conclusions: Our results of increased IL-6, IL-6 × sIL-6R, and sIL-2R in patients with SAD suggest an activation of the immune-inflammatory system in winter depression, which is not altered by 2 weeks of successful light therapy.

AB - Background: There is increasing evidence that an activation of the immune-inflammatory system is involved in the pathophysiology of depressive disorders. The purposes of this study were to (1) compare immune-inflammatory markers in patients with seasonal affective disorder (SAD) with those in matched normal controls; and (2) examine the effects of light therapy on the immune-inflammatory markers in patients with SAD. Methods: Plasma concentrations of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble IL-2 receptor (sIL-2R) were measured in 15 patients with SAD and 15 age- and sex-matched normal controls. Of the 15 patients, 14 had repeated blood sampling for these variables following 2 weeks of light therapy. Results: We found that patients with SAD had significantly increased IL-6 levels compared to normal controls (P <0.0005). There was a trend toward increased sIL-2R in patients with SAD (P = 0.09). There was no significant difference in sIL-6R level between the two diagnostic groups (P = 0.18), but the product term (IL-6 × sIL-6R) was significantly higher in patients with SAD than that in normal control controls (P <0.0003). Furthermore, all 14 patients who completed the study improved with 2 weeks of light therapy and nine of them (64%) had 50% reduction in score of the Hamilton Depression Rating Scale-SAD version post-treatment compared to baseline. However, the initially increased immune markers in SAD patients were not significantly altered by the therapeutic light therapy. Limitations: This study was limited to a small sample size and other immune inflammatory markers should be measured for further evidence of immune activation in seasonal depression. Conclusions: Our results of increased IL-6, IL-6 × sIL-6R, and sIL-2R in patients with SAD suggest an activation of the immune-inflammatory system in winter depression, which is not altered by 2 weeks of successful light therapy.

KW - Cytokines

KW - Interleukin-6

KW - Light therapy

KW - Seasonal affective disorder

KW - Soluble interleukin-2 receptors

KW - Soluble interleukin-6 receptors

KW - Winter depression

UR - http://www.scopus.com/inward/record.url?scp=0035089548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035089548&partnerID=8YFLogxK

U2 - 10.1016/S0165-0327(00)00165-8

DO - 10.1016/S0165-0327(00)00165-8

M3 - Article

VL - 63

SP - 27

EP - 34

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

IS - 1-3

ER -